Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Signal Twitter WhatsApp

Dollars for Doctors

How Industry Money Reaches Physicians

ProPublica is tracking the financial ties between doctors and medical companies.

GlaxoSmithKline to Quit Paying Doctors for Promotional Talks

The sixth-largest drug maker already had begun cutting back on paid speaking, ProPublica’s Dollars for Docs database shows.

Pay to Prescribe? Two Dozen Doctors Named in Novartis Kickback Case

The drug maker denies wrongdoing, but the Justice Department and a whistleblower say Novartis used cash and meals to get doctors to prescribe its drugs.

Heart of Nerd Darkness: Why Updating Dollars for Docs Was So Difficult

We updated Dollars for Docs last week. Why is updating it so difficult?

Dollars for Docs Mints a Millionaire

New data show drugmakers’ payments to hundreds of thousands of doctors, and some have made well over $500,000.

About the Dollars for Docs Data

Details behind our drug company money database.

Feds to Publicize Drug and Device Company Payments to Doctors Next Year

After a long delay, the U.S. Centers for Medicare and Medicaid Services published final rules for the Physician Payments Sunshine Act, which would bring transparency to financial relationships between physicians and industry.

Chatting With the Reporters Behind Dollars for Docs

Charlie Ornstein and Tracy Weber talk about the money docs get from drug companies, and why it matters.

American Pain Foundation Shuts Down as Senators Launch Investigation of Prescription Narcotics

Sens. Baucus and Grassley demand evidence of financial support from the drug industry to nonprofit groups that advocate use of opioid painkillers, including the newly defunct American Pain Foundation.

Allergan Erases Doctor Payment Records

You can still find some older Allergan payments in ProPublica's Dollars for Docs database, along with data from 11 other drug companies.

Senate Watchdog Targets High-Prescribing Medicaid Docs

Sen. Charles Grassley, R-Iowa, wants to know why an Ohio doctor wrote 54 prescriptions per weekday for the antipsychotic Abilify, while the biggest prescriber of Seroquel wrote an average nine prescriptions per hour.

Drug Companies Reduce Payments to Doctors as Scrutiny Mounts

Continued reporting on the influence of pharmaceutical money on medicine spurred tighter rules at medical schools across the nation.

The Champion of Painkillers

The annual death toll from overdoses of painkillers has reached almost 15,000, prompting the head of the Centers for Disease Control and Prevention to term it an "epidemic." But the American Pain Foundation continues to claim the risks are overblown. The advocacy group's biggest supporter? The drug industry.

Two Leaders in Pain Treatment Have Long Ties to Drug Industry

American Pain Foundation board members Scott Fishman and Perry Fine, both physicians, have lectured and authored publications funded by makers of narcotic painkillers. They say the support doesn’t bias them.

Government Runs Late With Rules For Disclosing Drug Company Payments to Doctors

The agency responsible for administering health care reform, the Centers for Medicare and Medicaid Services, published proposed rules last night, well after its Oct. 1 deadline.

Florida Sanctions Top Medicaid Prescribers — But Only After A Shove

Medicaid programs have long had evidence that a few physicians prescribed risky drugs in excess, but it wasn’t until Sen. Charles Grassley, R-Iowa, demanded to know the top prescribers that states began to investigate.

Government Misses Deadline for Rules Forcing Disclosure of Industry Payments to Doctors

The Obama administration has yet to draft rules on the disclosure of industry payments to doctors, missing a deadline set out in last year's health-care law. Drug and device companies, which are required to begin collecting payment data starting next year, are still awaiting such guidance.

Doctors Avoid Penalties in Suits Against Medical Firms

At least 15 drug and medical-device companies have paid $6.5 billion since 2008 to settle accusations of marketing fraud or kickbacks, but none of the more than 75 doctors named as participants were sanctioned.

News Reports Cite Drop in Physician Speaking Fees

Regional newspapers that analyzed ProPublica's Dollars for Docs data say drug company payments to physician speakers have declined in their states, suggesting that new restrictions and publicity are making an impact.

Patients Deserve to Know What Drug Companies Pay Their Doctor

ProPublica's newly updated Dollars for Docs database offers a glimpse of what patients can expect in 2013, when all drug and medical-device companies must report to the federal government what they pay doctors to help market their products.

Doctors Dine on Drug Companies’ Dime

Hundreds of thousands of doctors have accepted free meals from pharmaceutical companies that invite them to scientific or educational sessions. At least 20 physicians accepted more than $2,000 worth of meals from one company last year, ProPublica's Dollars for Docs database shows.

Follow ProPublica

Our Latest Stories

Current site Current page